Ace inhibitors

The results from the one-year phase 3 CHRONOS study have shown that patients receiving the investigational drug Dupilumab ( Dupixent...


Evolocumab ( Repatha ), a PCSK9 inhibitor, has shown to dramatically lower levels of low-density lipoprotein ( LDL), and also...


The FDA ( U.S. Food and Drug Administration ) has approved Xadago ( Safinamide ) tablets as an add-on treatment...


Researchers at the University of Texas MD Anderson Cancer Center in Houston, have found a link between microbes in the...


Verubecestat is an investigational small molecule inhibitor of the enzyme beta-site amyloid precursor protein cleaving enzyme 1 ( BACE1 )...


The Phase 3 SPIRE-AI ( AutoInjector ) trial of the investigational Proprotein Convertase Subtilisin Kexin type 9 inhibitor ( PCSK9i...


Cholesterol Ester Transfer Protein ( CETP ) inhibitors have been developed following the recognition of an association of CETP polymorphisms...


European Society of Cardiology ( ESC ) Guidelines for the diagnosis and treatment of acute and chronic heart failure are...


The FDA ( Food and Drug Administration ) has strengthened the existing warning about the risk of acute kidney injury...


The European Medicines Agency ( EMA ) has recommended granting marketing authorisations in the European Union ( EU ) for...


The FDA ( Food and Drug Administration ) has granted a Breakthrough Therapy Designation to the immunotherapy Darzalex ( Daratumumab...


Angioedema induced by treatment with angiotensin-converting-enzyme ( ACE ) inhibitors accounts for one third of angioedema cases in the emergency...


A study aimed to assess the relative efficacy and safety of biologics and Tofacitinib ( Xeljanz ) in patients with...


Hypertension is a common diabetes comorbidity that affects the majority of patients, with the prevalence depending on type of diabetes,...


Positive top-line results of the Kids B-LONG phase 3 clinical study that evaluated the safety, efficacy and pharmacokinetics of Alprolix...


When considering antiplatelet therapy for acute coronary syndrome ( ACS ), it is essential to balance benefits ( less thrombotic...


A new analysis of the TECOS ( Trial Evaluating Cardiovascular Outcomes with Sitagliptin ) trial has shown that patients...


A study has tested the hypothesis that risk factor pattern, treatment and prognosis differ between men and women with heart...


Evolocumab ( Repatha ) is a monoclonal antibody targeting proprotein convertase subtilisin/kexin type 9 ( PCSK9 ) that is administered...


New detailed data from the phase 3 YUKAWA-2 study evaluating Evolocumab ( Repatha ), a novel investigational cholesterol-lowering medication, in...